Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
LR.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LR.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KR.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-3774.92South Korea
KR.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-2361.24South Korea
KR.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-2824.15Germany
KR.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-3196.01Germany
KR.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-3064.43China
KR.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-3384China
KR.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-2013.34China
KR.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LQ.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
LQ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LQ.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
LQ.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
LQ.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
LQ.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
LQ.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LQ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDK.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XDK.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDK.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
XDK.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XDK.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XDK.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XDK.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XDK.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.4.8EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.1.4.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.4.8ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.1.4.8ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.1.4.8EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JN.1.4.8EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.1.4.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.4.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JF.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
JF.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JF.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
JF.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JF.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JF.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JF.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JF.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.3.19EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.2.3.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.19ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.2.3.19ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.2.3.19EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.2.3.19EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.2.3.19ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.3.19ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used